Literature DB >> 3083198

The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.

H M Cheng, R G González.   

Abstract

Diabetic cataractogenesis, a multifactorial process, was examined with nuclear magnetic resonance (NMR). P-31 NMR spectroscopic studies showed substantial alteration of both energy and membrane metabolism in the diabetic lens. Findings from a C-13 NMR spectroscopic determination of the sorbitol pathway flux in lenses incubated in 35.5 mmol/L glucose revealed that (1) one-third of total glucose consumed was channeled through this pathway, and (2) the turnover rate of NADPH to NADP was 3,000%/hr. Furthermore, a competition for NADPH between aldose reductase and glutathione reductase was demonstrated. It is important to note that all metabolic changes in hyperglycemic/diabetic lenses can be prevented by aldose reductase inhibitors, eg, sorbinil.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083198     DOI: 10.1016/0026-0495(86)90180-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  29 in total

1.  Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice.

Authors:  Srinivasan Vedantham; HyeLim Noh; Radha Ananthakrishnan; Ni Son; Kellie Hallam; Yunying Hu; Shuiquing Yu; Xiaoping Shen; Rosa Rosario; Yan Lu; Thyyar Ravindranath; Konstantinos Drosatos; Lesley Ann Huggins; Ann Marie Schmidt; Ira J Goldberg; Ravichandran Ramasamy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

2.  Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.

Authors:  Peng Zhang; Kuiyi Xing; James Randazzo; Karen Blessing; Marjorie F Lou; Peter F Kador
Journal:  Exp Eye Res       Date:  2012-06-15       Impact factor: 3.467

3.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 4.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

5.  Management of aldose reductase mRNA abundance in rat lens undergoing reversal of galactose induced cataracts. A model for gene response to changes in the environment.

Authors:  I Bekhor; S T Shi; N J Unakar
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

6.  Selenite and ebselen supplementation attenuates D-galactose-induced oxidative stress and increases expression of SELR and SEP15 in rat lens.

Authors:  Jie Dai; Jun Zhou; Hongmei Liu; Kaixun Huang
Journal:  J Biol Inorg Chem       Date:  2016-10-17       Impact factor: 3.358

7.  Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.

Authors:  A Y Lee; S K Chung; S S Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Thermal stress and diabetic complications.

Authors:  Y Ohtsuka; N Yabunaka; I Watanabe; H Noro; H Fujisawa; Y Agishi
Journal:  Int J Biometeorol       Date:  1995-01       Impact factor: 3.787

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  Lutein prevents cataract development and progression in diabetic rats.

Authors:  Emma Arnal; María Miranda; Inmaculada Almansa; María Muriach; Jorge M Barcia; Francisco J Romero; Manuel Diaz-Llopis; Francisco Bosch-Morell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.